Scopus BioPharma Inc.
SCPS · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $362 | $1,401 | $125 | $311 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $134 | $200 | $265 | $102 |
| Total Curr. Assets | $496 | $1,601 | $390 | $413 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $498 | $1,603 | $392 | $416 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $11,002 | $9,313 | $7,454 | $5,920 |
| Total Curr. Liab. | $11,002 | $9,313 | $7,454 | $5,920 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $11,002 | $9,313 | $7,454 | $5,920 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $40 | $40 | $21 | $21 |
| Retained Earnings | -$58,131 | -$55,515 | -$53,065 | -$51,334 |
| AOCI | $30 | $13 | -$5 | -$3 |
| Other Equity | $48,610 | $48,515 | $46,485 | $45,812 |
| Total Equity | -$9,452 | -$6,947 | -$6,564 | -$5,504 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1,053 | -$763 | -$498 | $0 |
| Total Liab. & Tot. Equity | $498 | $1,603 | $392 | $416 |
| Net Debt | -$362 | -$1,401 | -$125 | -$311 |